The liaison left. Thorne remained, staring at the hammer. He reached out, hovering his hand over the worn wooden handle.
in drug discovery. These molecules offer a middle ground between small-molecule drugs and large biologics, providing the high specificity of antibodies with the potential for better tissue penetration. If "KBI-058" refers to a specific project from KBI Biopharma KBI-058
It’s exhausting just to look at it.
DYRK1A is a proline-directed kinase encoded on human chromosome 21. Its overexpression is implicated in early-onset neurodegeneration and cognitive dysfunction. Current therapeutic options remain symptomatic; thus, selective DYRK1A inhibitors are highly sought after. Through a structure-based virtual screen of a 500,000-compound library, followed by hit-to-lead optimization, we identified (IUPAC: N-(3-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl)-2,4-difluorobenzenesulfonamide ). This paper describes its preclinical profile. The liaison left